“Oxybutynin and tolterodine for treatment of neurogenic detrusor overactivity: a pharmacoeconomic evaluation in the Brazilian context” (2012) Brazilian Journal of Pharmaceutical Sciences, 48(2), pp. 227–236. doi:10.1590/S1984-82502012000200006.